Treatment of benign breast disease with bromocriptine

[1]  R. Deitch.  Commentary from Westminster. Abortion (Amendment) Bill. , 1980, Lancet.

[2]  T. G. Muldoon.  Characterization of mouse mammary tissue estrogen receptors under conditions of differing hormonal backgrounds. , 1978, Journal of steroid biochemistry.

[3]  F. Di Carlo,et al.  Interference of gestagens and androgens with rat uterine oestrogen receptors. , 1978, The Journal of endocrinology.

[4]  B. Andersch,et al.  Treatment of premenstrual tension syndrome with bromocriptine. , 1978, Acta endocrinologica. Supplementum.

[5]  W. Malarkey,et al.  Disordered nocturnal prolactin regulation in women with breast cancer. , 1977, Cancer research.

[6]  McManus Mj,et al.  Stimulation of DNA Synthesis by Human Placental Lactogen or Insulin in Organ Cultures of Benign Human Breast Tumors , 1977 .

[7]  J. Larsen,et al.  EFFECT OF BROMOCRIPTINE ON THE PREMENSTRUAL SYNDROME. A DOUBLE‐BLIND CLINICAL TRIAL , 1977, British journal of obstetrics and gynaecology.

[8]  B. Palmer,et al.  Bromocriptine for severe mastalgia. , 1977, British medical journal.

[9]  J. Djiane,et al.  Prolactin–progesterone antagonism in self regulation of prolactin receptors in the mammary gland , 1977, Nature.

[10]  Ward Hw.  Combined anti-prolactin and anti-oestrogen therapy for breast carcinoma. , 1977 .

[11]  S. Brooks,et al.  Effect of prolactin on growth and the estrogen receptor level of human breast cancer cells (MCF-7). , 1977, Cancer research.

[12]  A. Coppen,et al.  Bromocriptine and premenstrual syndrome: controlled study. , 1977, British medical journal.

[13]  C. Robyn,et al.  Prolactin and human reproduction , 1977 .

[14]  V. Cararach,et al.  Treatment of Fibrocystic Disease of the Breast With a Prolactin Inhibitor: 2-Br-Alpha- Ergocryptine (CB-154) , 1976, Obstetrics and gynecology.

[15]  L. J. Benedek-Jaszmann,et al.  PREMENSTRUAL TENSION AND FUNCTIONAL INFERTILITY Aetiology and Treatment , 1976, The Lancet.

[16]  H. Rochefort,et al.  Regulation of estrogen receptors in ovarian-dependent rat mammary tumors. I. Effects of castration and prolactin. , 1976, Endocrinology.

[17]  K. Chihara,et al.  Plasma prolactin responses to thyrotropin‐releasing hormone in patients with breast cancer , 1976, Cancer.

[18]  C. Robyn.  [Prolactin and breast cancer]. , 1975, Pathologie-biologie.

[19]  D. Pugsley,et al.  POTENTIAL PITFALL IN BIOASSAY OF SERUM-GENTAMICIN , 1975, The Lancet.

[20]  M. Pike,et al.  Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer. , 1975, The New England journal of medicine.

[21]  L. Sherman,et al.  Prolactin and breast carcinoma. , 1975, The New England journal of medicine.

[22]  A. Barrett,et al.  Prolactin-dependent breast cancer. , 1975 .

[23]  V. Seagroatt,et al.  Prolactin Concentrations in Patients with Breast Cancer , 1974, British medical journal.

[24]  F. Cleton,et al.  Plasma-prolactin in human breast cancer. , 1974, Lancet.

[25]  Gordon Hiroshi Sasaki,et al.  Prolactin and progesterone effect on specific estradiol binding in uterine and mammary tissues in vitro. , 1973, Biochemical and biophysical research communications.

[26]  R. G. Wilson,et al.  Plasma prolactin in breast cancer. , 1973, European journal of cancer.

[27]  E. Pozo,et al.  THE INHIBITION OF PROLACTIN SECRETION IN MAN BY CB-154 (2-Br-α-ergocryptine) , 1972 .

[28]  A. Segaloff.  Hormones and breast cancer. , 1966, Recent progress in hormone research.